[Evaluation of genetic consequences of 238Pu incorporation into mammals]. 1988

M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia

The genetic effects of gonadal burdens of 238Pu after single injection were studied in male mice. The activity of plutonium was 7 to 1850 Bk/g. The average doses of accumulated alpha-particles in testis varied from 2 to 96 Gy.10(-2), the dose rate being 0.004 to 1 Gy.10(-2) per day. The genetic end points are: the dominant lethal mutation rate; the frequency of reciprocal translocations; the recessive lethal mutation rate and frequency of abnormal sperm head morphology. For all tests used, no linear dependence of the effect on the alpha-dose was observed. The RBE value of alpha-irradiation was 10-20 relative to chronic gamma-irradiation.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D012062 Relative Biological Effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Biological Effectiveness, Relative,Effectiveness, Biologic Relative,Effectiveness, Biological Relative,Relative Biologic Effectiveness,Biologic Effectiveness, Relative,Biologic Relative Effectiveness,Biological Relative Effectiveness,Effectiveness, Relative Biologic,Effectiveness, Relative Biological,Relative Effectiveness, Biologic
D001822 Body Burden The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal. Body Burdens,Burden, Body,Burdens, Body
D005260 Female Females
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D005804 Genes, Lethal Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability. Alleles, Lethal,Allele, Lethal,Gene, Lethal,Lethal Allele,Lethal Alleles,Lethal Gene,Lethal Genes

Related Publications

M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
June 1989, Mutation research,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
December 2012, Trends in genetics : TIG,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
August 1997, Biochemical pharmacology,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
February 2021, Critical reviews in biochemistry and molecular biology,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
December 1967, Biochimica et biophysica acta,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
January 1985, Ontogenez,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
August 2016, Angewandte Chemie (International ed. in English),
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
December 1984, Antiviral research,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
January 1979, Radiation research,
M D Pomerantseva, and L K Ramaĭia, and V A Shevchenko, and G A Vilkina, and A M Liaginskaia
May 1963, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!